Clinical Trial Update: Clinical Practice of AECOPD Management in China

View source ↗

Summary

An update on how acute exacerbations of chronic obstructive pulmonary disease are managed in clinical practice in China. The study is sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Acute Exacerbation of Chronic Obstructive Pulmonary Disease | Status: COMPLETED